Cell Genesys (CEGE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tom Hua who wrote (786)	3/17/2000 10:06:00 PM
From: Timoteo	Read Replies (2) of 1298

It may be a while before fund managers buy into the biotech sector, but one never knows. I think many people are still unaware of the whole CEGE story-specifically the cash and ABGX share. It doesn't show in any of the typical profiles so if one doesn't do the DD CEGE is just another "overpriced" biotech. One of my few other tech holdings is BRKT, which is a great company that dropped about 30% this week for no reason. Many investors don't realize that they own 6 million shares of ISPD which is worth more than half BRKT's current market cap. I guess the key is just patience. Best, Timoteo

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next